Global markets
European cannabis markets.
Europe is not one market. Regulation, product categories, distribution, demand and market access differ sharply between countries — so we assess each on commercial merit and a realistic route to revenue.
Regions
Indicative regions only. No claim of operations in any specific country.
Country markets
Each assessment covers the regulatory environment, medical and adult-use structures, cannabinoid products, distribution, business models, entry considerations and risks.
GermanyEurope's largest demand pool and the reference market for medical supply.SwitzerlandNon-EU, high-value, and unusually open to controlled experimentation.PortugalA production and export base more than a domestic consumer market.SpainLarge informal culture, narrow formal commercial ground.Czech RepublicReform-minded, pragmatic, and unusually open to cannabinoid products.NetherlandsFamous retail model, tightly closed commercial access.PolandLarge population, pharmacy-led access, growing medical demand.FranceBig consumer base, restrictive framework, careful positioning required.ItalyEstablished hemp sector, shifting rules on consumer cannabinoids.AustriaSmall, orderly, and a useful proving ground for DACH strategy.
Working out where to start? Read how to read a new cannabinoid market, score a country with the cannabis market entry calculator, or see our cannabis consulting services.
Have a problem inside your cannabis business?
Tell us what you're trying to build, where you're stuck and what you're trying to achieve.